Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.
A group of 20 healthy volunteers underwent a 35% carbon dioxide/65% oxygen air-placebo controlled challenge test twice, premedicated 1 h before with either 20 mg yohimbine or placebo, following a double-blind randomized crossover design. Contrary to expectation the anxiety response to carbon dioxide was not higher when premedicated with yohimbine compared to premedication with placebo. Possible implications of this finding are discussed, with reference to general chemical models of panic.
Pols
H
H
State University of Limburg, Academic Psychiatric Center, Maastricht, The Netherlands.
Griez
E
E
Verburg
K
K
van der Werf
D
D
D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000139:chemically induced* / Q000503:physiopathology; D002245:Carbon Dioxide; D005260:Female; D006801:Humans; D008125:Locus Coeruleus / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D009638:Norepinephrine / Q000502:physiology; D010200:Panic / Q000187:drug effects* / Q000502:physiology; D011292:Premedication; D015016:Yohimbine / Q000494:pharmacology*
D002245:Carbon Dioxide; D015016:Yohimbine; D009638:Norepinephrine